ArticleCancer medicine2025
Impact of Immigration Status on Survival Among Stage 1 and 2 HER2-Positive and Triple-Negative Breast Cancer in Ontario, Canada.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Kidney function changes associated with trastuzumab use in women with breast cancer: a retrospective cohort study.Breast cancer research and treatment · 2026Article
- Mammographic screening and time to breast cancer diagnosis among immigrants and long-term residents in Ontario.BMC cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study examined death from breast cancer and death from other causes among women with Stage 1 and 2 Her2-positive and triple-negative breast cancer (BC) by immigration status.
methodsWe identified women aged 18-75 diagnosed with BC in Ontario from January 1, 2012, to December 31, 2019, followed them to December 31, 2023, and identified legal immigrants from the Immigration, Refugee, and Citizenship Canada Permanent Resident (CIC) database. We linked administrative data sources for the date of diagnosis, molecular subtype, death due to breast cancer, and death due to all other causes. Using adjusted competing risks regression (Fine and Gray method), we analyzed the influence of immigration on breast cancer survival and calculated the sub-distribution hazard ratios (sHR).
resultsThere was no increased risk of death among legal immigrants on univariate or multivariable analysis. They had a sHR of 0.95 (0.77-1.19) on univariate analysis and 1.06 (95% CI: 0.83-1.36) on multivariable analysis for breast cancer deaths, and for other causes of death, 0.63 (0.47-0.83) on univariate analysis, and 0.85 (95% CI: 0.62-1.15) on multivariable analysis compared to long-term residents. Patients with HER2-positive status had a lower risk of death from breast cancer and other causes compared to those with triple-negative breast cancer (TNBC). Patients with Stage 2 cancer had a significantly higher hazard of death from breast cancer compared to Stage 1 (HR = 3.72, 95% CI: 2.96-4.66, p < 0.0001).
conclusionsIn Ontario, legal immigrants do not have an increased risk of death from breast cancer or other causes compared to long-term residents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.